1.Discussion on correlation between intrahepatic inflammatory pathogenesis and the TCM theory of liver collateral injury by toxins in patients of type 2 diabetes mellitus with insulin resistance.
Miao YU ; Chun-li PIAO ; Zheng NAN
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(11):1032-1034
Correlation between the intrahepatic inflammatory pathogenesis and the TCM theory of liver collateral injury by toxins in patients of type 2 diabetes mellitus (T2DM) with insulin resistance (IR) was investigated, to elucidate that removing toxins, dredging collateral and modulating Gan could be one of the effective approaches for inhibiting intrahepatic inflammation mechanism of T2DM with IR.
Chemokine CCL2
;
metabolism
;
Diabetes Mellitus, Type 2
;
complications
;
metabolism
;
physiopathology
;
Diagnosis, Differential
;
Humans
;
Inflammation
;
etiology
;
metabolism
;
physiopathology
;
Insulin Resistance
;
Liver
;
metabolism
;
pathology
;
physiopathology
;
Medicine, Chinese Traditional
;
NF-kappa B
;
metabolism
2.Neonatal intrahepatic cholestasis caused by citrin deficiency:updated understanding
Jingying LIU ; Jingkun MIAO ; Yuanyuan HUA ; Huijuan LIU ; Qian MA ; Chun LI ; Jialin YU ; Qixiong CHEN
Journal of Clinical Pediatrics 2016;34(12):949-953,955
Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is an autosomal recessive disease caused by SLC25A13 gene mutations, and is characterized by delayed jaundice clearance, liver dysfunction, and elevated aminoacidemia. The confirmed diagnosis depends on gene analysis. Citrin deficiency is one of the important causes of neonatal intrahepatic cholestasis in China. Recently more and more researches about NICCD were reported. The paper summarized the epidemiology, pathogenesis, clinical characteristics, and progresses in diagnosis and treatment of NICCD.
3.Advances on Keap1-Nrf2 protein-protein interaction inhibitors and degraders
Jian-yu YAN ; Guo-dong LIU ; Zhen-yuan MIAO ; Chun-lin ZHUANG
Acta Pharmaceutica Sinica 2022;57(10):2932-2948
Oxidative stress is a redox imbalance in the body, which is one of the important factors leading to tissue damage and diseases. The nuclear factor E2-related factor 2 (Nrf2)-Kelch like ECH-associated protein 1 (Keap1) signaling pathway is not only an important defense system against oxidative damage, but also one of the key signaling pathways of the antioxidant capacity. Numerous studies have shown that targeting the Keap1-Nrf2 signaling pathway to activate Nrf2 has become an effective strategy for the treatment of oxidative stress and related diseases. Using small molecules to directly block the Keap1-Nrf2 protein-protein interaction (PPI) is one of the important directions for activating Nrf2 and exerting the cytoprotective effect, which can avoid the potential side effects of covalent modification of Nrf2. On the other hand, the Keap1 is an efficient E3 ubiquitin ligase that has been used in the design of proteolysis targeting chimeras (PROTACs). This review summarizes the research progresses of Keap1-Nrf2 protein interaction inhibitors and degraders based on the Keap1 E3 ubiquitination system in recent years.
4.Advances in studies on eudistomin marine alkaloids.
Xiao-chun DONG ; Yu-ping MIAO ; Zhi-gang LIN ; Fan YU ; Ren WEN
Acta Pharmaceutica Sinica 2003;38(11):876-880
5.Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis.
Jie CHEN ; Chun Xiang TIAN ; Miao YU ; Qing LV ; Nan Sheng CHENG ; Zu WANG ; Xi WU
Journal of Breast Cancer 2014;17(1):61-68
PURPOSE: The aim of the study was to evaluate the efficacy and safety of combining sorafenib with chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. METHODS: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, American Society for Clinical Oncology abstracts, and European Society for Medical Oncology abstracts were searched. Randomized clinical trials that compared the efficacy and safety of sorafenib plus chemotherapy in patients with HER2-negative advanced breast cancer with placebo plus chemotherapy were eligible. The endpoints were progression-free survival (PFS), overall survival (OS), time to progression (TTP), duration of response (DOR), overall response rate (ORR), clinical benefits, and adverse effects. The meta-analysis was performed using Review Manager 5.2.6 (The Nordic Cochrane Centre), and the fixed-effect model weighted by the Mantel-Haenszel method was used. When considerable heterogeneity was found (p<0.1), further analysis (subgroup analysis, sensitivity analysis, or random-effect model) was performed to identify the potential cause. The results are expressed as hazard ratios or risk ratios, with their corresponding 95% confidence intervals. RESULTS: The final analysis included four trials comprising 844 patients. The results revealed longer PFS and TTP, and higher ORR and clinical benefit rates in patients receiving sorafenib combined with chemotherapy compared to those receiving chemotherapy and placebo. OS and DOR were similar in the two groups. Meanwhile, the incidence of some adverse effects, including hand-foot skin reaction/hand-foot syndrome, diarrhea, rash, and hypertension, were significantly higher in the sorafenib arm. CONCLUSION: Sorafenib combined with chemotherapy may prolong PFS and TTP. This treatment was associated with manageable toxicities, but frequent dose interruptions and reductions were required.
Arm
;
Breast Neoplasms*
;
Breast*
;
Diarrhea
;
Disease-Free Survival
;
Drug Therapy*
;
Exanthema
;
Humans
;
Hypertension
;
Incidence
;
Medical Oncology
;
Odds Ratio
;
Population Characteristics
;
Receptor, Epidermal Growth Factor
;
Skin
;
Treatment Outcome
6.Study of large medical equipment allocation in Xuzhou.
Chun-xia MIAO ; Lang ZHUO ; Yu-ming GU ; Zhao-hui QIN
Journal of Zhejiang University. Science. B 2007;8(12):881-884
OBJECTIVETo investigate the allocation and management of large medical equipment (LME) in Xuzhou, Jiangsu Province, China, in order to make the best use of LME to meet the medical needs of local people.
METHODSThe research collected data from all hospitals that have LME in Xuzhou using questionnaire; 38 (97.4%) hospitals returned the questionnaire.
RESULTSIn Xuzhou, there are a total of 71 pieces of LME, each serving 126 600 people in an area of 163 km(2). Sixty-two percent of them are allocated in urban areas, with Gini coefficient at 0.52, indicating imbalance and biased allocation of LME.
CONCLUSIONThe allocation of LME in Xuzhou is out of control and unfairly allocated.
China ; Equipment and Supplies ; Hospitals ; Medical Laboratory Science ; Surveys and Questionnaires
7.Development of reversible oviductal polyethylene contraceptive plugs.
Su-Chun LI ; Wei-Ming LING ; Shun-Ming YU ; Miao FENG
Chinese Journal of Medical Instrumentation 2008;32(2):105-107
An introduction of the design, features and contraceptive principle of an oviduct contraceptive plug is given in this paper. The plug is made of polyethylene, based on the oviductal morphology. It can be introduced and removed by a hysteroscope and is expected to be a transcervical, implantable and permanent intratubal contraceptive device.
Contraceptive Devices, Female
;
Equipment Design
;
Polyethylene
;
Sterilization, Tubal
;
instrumentation
8.Clinical features and prognosis analysis of different breast cancer molecular subtypes.
Qian YANG ; Jie CHEN ; Hong-Jiang LI ; Miao YU ; Chun-Xiang TIAN ; Qing LÜ
Chinese Journal of Oncology 2011;33(1):42-46
OBJECTIVETo investigate the clinical characteristics and prognosis of different breast cancer molecular subtypes.
METHODSClinicopathological and follow-up data of 1153 cases of operable breast cancer were analyzed retrospectively. Their molecular subtypes were categorized as luminal A, luminal B, Her-2 over-expressing and basal-like subtypes, based on detection of ER, PR, Her-2 expression. The correlation of prognosis of different molecular subtypes with age, tumor size, lymph node status and clinical staging was analyzed.
RESULTSAmong the 1153 cases, 791 cases (68.6%) were of luminal A subtype, 50 cases (4.3%) luminal B subtype, 53 cases (4.6%) Her-2(+)subtype, and 259 cases (22.5%) basal-like subtype. There were no statistically significant differences among different molecular subtypes regarding the age, tumor size, lymph node status, and clinical stage. 1006 cases had complete follow-up data and the analysis showed that distant metastasis of Her-2 over-expressing subtype was significantly higher than that in other subtypes (P = 0.005), but the differences of local recurrence rate in different molecular subtypes was not statistically significant (P > 0.05). Kaplan-Meier method was used to analyze the survival prognosis of different molecular subtypes, showing both DFS rate and OS rate of Her-2 over-expressing subtype were the lowest, with a statistically significant difference (Log rank test, P < 0.05). Univariate and multivariate analyses showed that molecular typing and lymph node status were independent prognostic factors affecting both DFS and OS.
CONCLUSIONSHer-2 over-expressing subtype has the worst prognosis. Molecular subtypes may provide important information to predict the prognosis of breast cancer and might be an important basis for individualized treatment of breast cancer in future.
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms ; classification ; metabolism ; pathology ; therapy ; Carcinoma, Ductal, Breast ; classification ; metabolism ; pathology ; therapy ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Mastectomy ; methods ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Proportional Hazards Models ; Radiotherapy, Adjuvant ; Receptor, ErbB-2 ; metabolism ; Receptors, Estrogen ; metabolism ; Receptors, Progesterone ; metabolism ; Retrospective Studies ; Survival Rate ; Young Adult
9.NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia
Chun-Chun WEI ; Yuan-Yuan KONG ; Xia HUA ; Guo-Qiang LI ; Si-Li ZHENG ; Ming-He CHENG ; Pei WANG ; Chao-Yu MIAO
Chinese Journal of Pharmacology and Toxicology 2018;32(4):311-311
OBJECTIVE Tissue plasminogen activator (tPA) is the only approved pharmaco-logical therapy for acute brain ischaemia;however,a major limitation of tPA is the haemorrhagic trans-formation that follows tPA treatment. Here, we determined whether nicotinamide mononucleotide (NMN), a key intermediate of nicotinamide adenine dinucleotide biosynthesis, affects tPA-induced haemorrhagic transformation. METHODS Middle cerebral artery occlusion (MCAO) was achieved in CD1 mice by introducing a filament to the left MCA for 5 h.When the filament was removed for reperfusion, tPA was infused via the tail vein.A single dose of NMN was injected i.p.(300 mg·kg-1).Mice were killed at 24 h post ischaemia, and their brains were evaluated for brain infarction, oedema, haemoglobin content, apoptosis, neuroinflammation, blood-brain barrier (BBB) permeability, the expression of tight junction proteins(TJPs)and the activity/expression of MMPs. RESULTS In the mice infused with tPA at 5 h post ischaemia, there were significant increases in mortality, brain infarction, brain oedema, brain haemoglobin level, neural apoptosis, Iba-1 staining (microglia activation) and myeloperoxidase staining (neutrophil infiltration). All these tPA-induced alterations were significantly prevented by NMN administration. Mechanistically, the delayed tPA treatment increased BBB permeability by down-regulating TJPs, including claudin-1, occludin and zonula occludens-1,and enhancing the activities and protein expression of MMP9 and MMP2. Similarly, NMN administration partly blocked these tPA-induced molecular changes. CONCLUSION Our results demonstrate that NMN ameliorates tPA-induced haemorrhagic transformation in brain ischaemia by maintaining the integrity of the BBB.
10.The estrogen-like protective effect of ginsenoside Rb3 on oxidative stress and dysfunction of endothelial cells induced by oxidized low-density lipoprotein.
Yu-ting PAN ; Chun-yu GUO ; Xiao-juan MA ; Jing-shang WANG ; Xin LIU ; Ming-yue SUN ; Miao ZHANG ; Hui-jun YIN
Acta Pharmaceutica Sinica 2014;49(10):1406-1412
Ginsenoside Rb3 (GRb3) is one of the main components in plasma of Panax quinquefolius Saponin of stem and leaf (PQS), which can be into human plasma. Previous studies have found PQS has estrogen-like vascular protective effects. In the present study, we investigated the estrogen-like protective effect of GRb3 on oxidative stress and dysfunction of endothelial cells induced by oxidized low-density lipoprotein. The activities of SOD, NOS and the contents of MDA in the cell lysate were examined by enzyme method or spectrophotometry. The NO and ET-1 concentrations in the cell culture supernatant were measured by ELISA method. The iNOS and eNOS mRNA expression were measured by real time RT-PCR, while the phosphorylation levels of Akt was measured by Western blotting. The results showed that GRb3 could enhance the activity of SOD, reduce the content of MDA, increase the level of NOS, NO, ET-1 and iNOS mRNA expression while decrease the eNOS mRNA expression and the phosphorylation level of Akt. These effects were blocked by estrogen receptor antagonist ICI182780. GRb3 can play a role in protecting vascular endothelial cells by estrogen receptors, the protective mechanism is similar to 17-β estrodiol.
Cells, Cultured
;
Endothelial Cells
;
drug effects
;
Endothelin-1
;
metabolism
;
Estradiol
;
analogs & derivatives
;
Estrogens
;
pharmacology
;
Ginsenosides
;
pharmacology
;
Humans
;
Lipoproteins, LDL
;
adverse effects
;
Nitric Oxide Synthase Type II
;
metabolism
;
Nitric Oxide Synthase Type III
;
metabolism
;
Oxidative Stress
;
Panax
;
chemistry
;
Phosphorylation
;
Saponins
;
pharmacology
;
Superoxide Dismutase
;
metabolism